Arrowpoint Investment Partners (Singapore) Pte. Ltd.

Position in NBIX — Neurocrine Biosciences Inc

CIK 2032331 SINGAPORE, U0

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,839,787

+$2,340,971 QoQ

Shares Held

21,556

+512.9% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

4.54%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $4,293,255 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (66.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	21,556	$2,839,787
2	TEVA	Teva Pharmaceutical Industries Ltd	25,805	$777,246
3	BIOA	BioAge Labs, Inc.	20,796	$363,722
4	UTHR	UNITED THERAPEUTICS Corp	527	$312,500

All Filings in NBIX

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,839,787	21,556	+512.9%	Shares	Defined	2026-05-14
2025-12-31	$498,816	3,517	—	Shares	Defined	2026-02-11
No filing history on record for this holder in this stock.